Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma

Completed · Phase 2

Conditions studied: Thymoma and Thymic Carcinoma

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to compare the effectiveness of octreotide alone or with prednisone in treating patients with metastatic or recurrent thymoma.

Key facts

Study ID
NCT00003283
Run by
Eastern Cooperative Oncology Group
People needed
38
Starts
1998-10-13
Last updated by the study team
2023-06-15

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.